Peter van de Sande
Algemeen Directeur bij SynAffix BV
Actieve functies van Peter van de Sande
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
SynAffix BV
 SynAffix BV BiotechnologyHealth Technology SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - |
Loopbaan van Peter van de Sande
Eerdere bekende functies van Peter van de Sande
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Corob Oy
 Corob Oy Industrial SpecialtiesProcess Industries Corob Oy supplies color tinting systems. It offers complete tinting solutions: CPSCOLOR TM colorants (liquid pigments), COROB TM dispensing and mixing/shaking equipment, software, color marketing tools, customer support and service. The firm serves paint manufacturers, retail chains, leather and plastics producers. The company was founded in 2000 and is headquartered in Pori, Finland. | Verkoop & Marketing | - | - |
Opleiding van Peter van de Sande
| Technische Universiteit Eindhoven | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
| The University of Sydney | Graduate Degree |
Statistieken
Internationaal
| Nederland | 3 |
| Verenigde Staten | 2 |
| Australië | 2 |
Operationeel
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
| Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
SynAffix BV
SynAffix BV BiotechnologyHealth Technology SynAffix BV develops next-generation antibody-drug conjugates for targeted cancer and other diseases. The application of the firm?s proprietary GlycoConnect technology, comprising precision modification of a protein's native glycosylation site, allows the fast and simple construction of antibody-drug conjugates that are both stable and homogeneous. The company was founded by Floris van Delft and Sander van Berkel in 2010 and is headquartered in Oss, the Netherlands. | Health Technology |
Corob Oy
Corob Oy Industrial SpecialtiesProcess Industries Corob Oy supplies color tinting systems. It offers complete tinting solutions: CPSCOLOR TM colorants (liquid pigments), COROB TM dispensing and mixing/shaking equipment, software, color marketing tools, customer support and service. The firm serves paint manufacturers, retail chains, leather and plastics producers. The company was founded in 2000 and is headquartered in Pori, Finland. | Process Industries |
- Beurs
- Insiders
- Peter van de Sande
- Ervaring
